Recombinant Protein Market to Surpass US$ 6,691.4 Million by 2030, Says Coherent Market Insights (CMI)
Burlingame, Feb. 08, 2023 (WORLD NEWSWIRE) — According to Coherent Market Insights, international
recombinant protein
market
is approximated to be valued at
US$
2,808.4
million
in
2022
and is anticipated to show a
CAGR
of
11.5
%
throughout the projection duration
(2022-2030
).
Key Trends and Analysis of the
Global
Recombinant Protein
Market
:
Increasing efforts and research study programs for antibody production is anticipated to help in the sector development over the projection duration. For circumstances, in January 2022, Vir Biotechnology, Inc., a commercial-stage immunology business, revealed the extension of its collaboration with the Bill & Melinda Gates Foundation for introducing a brand-new antibody research study effort.
Request Sample copy of this Report @
Key Market Takeaways:
The international recombinant protein market is anticipated to show a
CAGR of
11.5
%
throughout the projection duration. Due to crucial gamers in the market are associated with item launches of protein supplements. For circumstances, in March 2022, Muscle Pharm Corporation, an international manufacturer of sports nutrition and way of life branded dietary supplements, revealed its entry into the ready-to-drink protein market in the summer season of 2022, with the launching of its brand-new whey protein beverage line. The brand-new variety of high protein drinks will be offered under the popular Muscle Pharm brand name and will have more than 20g of protein, be sugar-free, and be available in a range of tastes.
Among item type, antibodies sector is dominant due to the increasing adoption of inorganic development methods such as acquisitions by the crucial gamers is anticipated to drive the sector development over the projection duration. For circumstances, in July 2021, Atlas Antibodies, producer of extremely confirmed main antibodies, obtained evitria, a designer of short-term recombinant antibody expression in Chinese hamster ovary (CHO) cells. CHO cells are the chosen expression system for recombinant restorative protein (RTP) production. The acquisition will integrate the antibody services of both the business and broaden their business.
On the basis of end user, biotechnology and pharmaceutical business sector is anticipated to hold dominant position over the projection duration. Due to increasing fund raising activities by market gamers for the advancement of drugs. For circumstances, in December 2021, PDC line Pharma, a scientific phase biotech business establishing a brand-new class of powerful and scalable active off the-shelf cancer vaccine, revealed the conclusion of its Series B2 round of funding. The business had actually raised an overall of US$ 20.3 million (€17.5 million) with Belgian and South Korean financiers. The follows series B financing round will be utilized for the stage I/II trial of PDC lung01, among the class of active immunotherapies for cancers that the business is establishing based upon GMP-grade allogeneic therapies cell line of plasmocytoid dendritic cell- its PDC line.
Competitive Landscape:
Key gamers running in the international
recombinant protein
market consist of Merck KGaA, OriGene Technologies, Inc., Thermo Fisher Scientific Inc., Feldan Therapeutics, ACROBiosystems, Abcam plc., Randox Laboratories Ltd., SOL GROUP, Proteintech Group, Inc, Planet Biotechnology, Inc., INFINITE ENZYMES, INC., ORF Genetics, GenScript, BTL Biotechno Labs Pvt Ltd., Prospec-Tany Technogene Ltd., BPS Bioscience, Inc., Sino Biological, Cape Bio Pharms, Abnova Corporation, GeNext Genomics.
Buy-Now this Research Report @
Market Segmentation:
-
Global Recombinant Protein Market, By Product Type:
- Antibodies
- Antigens
- Enzymes
- Hormones
- Others
-
Global Recombinant Protein Market, By Expression System:
-
Global Recombinant Protein Market By Application:
- Drug Discovery and Development
- Research Application
- Therapeutic Use
- Diagnostics
- Others
-
Global Recombinant Protein Market By End User:
- Biotechnology and Pharmaceutical Companies
- Academic and Research Institute
- Contract Research Organization
- Others
-
Global Recombinant Protein Market, By Region:
Related Market Intelligence Reports:
Single-Use Bioreactor Market
, By Product (Single-usage Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), By Cell Type (Mammalian Cell, Bacteria, Yeast, and Other Cell Types), By Molecule Type (Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins, and Other Molecule Types), By End User (Pharmaceutical and Biopharmaceutical Industries and Contract Research Organizations (CRO) Other End Users), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2028
Pulmonary Surfactant Market
, by Type (Synthetic Pulmonary Surfactant,Animal Derived Surfactant), by Drug Type (Poractant alfa, Lucinactant, Calfactant), by Indications (Respiratory Distress Syndrome (RDS), Respiratory Infections, Obstructive lung Diseases, Others(persistent lung illness of prematurity, and surfactant protein-B shortage)), by Route of Administration (Intratracheal, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030
About Us:
Coherent Market Insights
is an international market intelligence and consulting organization concentrated on helping our variety of customers accomplish transformational development by assisting them make important business choices. We are headquartered in India, having sales workplace at international monetary capital in the U.S. and sales specialists in United Kingdom and Japan. Our customer base consists of gamers from throughout different business verticals in over 57 nations worldwide. We produce worth for customers through our extremely trusted and precise reports. We are likewise devoted in playing a leading function in providing insights in different sectors post-COVID-19 and continue to provide quantifiable, sustainable outcomes for our customers.
Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: United States: +1-206-701-6702 UK: +44-020-8133-4027 Japan: +81-050-5539-1737 India: +91-848-285-0837 Email: [email protected] Website:
